Dublin's St. Vincent's Private Hospital is Site of the 1,000th Oncentra Brachy for Planning Cancer Treatments with Brachytherapy

- With Photo

- Nucletron, an Elekta company, reaches major milestone with its brachytherapy treatment planning software

DUBLIN, April 23, 2012 /PRNewswire/ -- St. Vincent's Private Hospital (Dublin, Ireland) has installed Oncentra® Brachy, becoming the site of the 1,000th brachytherapy treatment planning software manufactured by Nucletron, an Elekta company. Oncentra was introduced in the global market in 2008 and is Nucletron's software platform for radiotherapy treatment planning.

(Photo:  http://photos.prnewswire.com/prnh/20120423/CL91577 )

With over 25 years of experience, Nucletron has put all its knowledge and utmost care into making advanced treatment planning tools that are fast and reliable, giving healthcare professionals the confidence of providing precisely targeted radiation therapy. Oncentra Brachy is a comprehensive and user-friendly software solution that includes advanced algorithms to ensure efficient and highly accurate brachytherapy treatment planning. It fits seamlessly into Nucletron's solutions for brachytherapy imaging and treatment delivery and can be seamlessly integrated with Oncentra External Beam, with IMRT/VMAT and proton planning capabilities.

"We selected Nucletron's Oncentra Brachy software because it is state-of-the-art, user friendly and ensures precise cancer treatment," says Michael Redmond, CEO of St. Vincent's. "And, because our hospital operates Elekta treatment machines, as well, we hope to have a mutually beneficial relationship with both Nucletron and Elekta."

The combined offering of Nucletron and Elekta solutions presents a formidable range of radiotherapy planning and delivery technologies that will benefit both patients and healthcare providers, adds Patrick Greally, Elekta Ireland Business Unit Managing Director.

"We are delighted to work with our colleagues on this project at St. Vincent's Private Hospital," he says.

To learn more about the Oncentra Brachy software system, visit www.nucletron.com/Oncentra.

For further information, please contact:

Gert van Santen, Communications Director, Nucletron an Elekta company
Tel +31-6-5356-1242, email: gert.vansanten@elekta.com
Time zone: Central European Time

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46-8-587-254-37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1-770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

Note to Editors: A picture accompanying this release is available through the PA Photowire. It can be downloaded from http://www.pa-mediapoint.press.net  or viewed at http://www.mediapoint.press.net  or http://www.prnewswire.co.uk.